JP2010534684A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010534684A5 JP2010534684A5 JP2010518431A JP2010518431A JP2010534684A5 JP 2010534684 A5 JP2010534684 A5 JP 2010534684A5 JP 2010518431 A JP2010518431 A JP 2010518431A JP 2010518431 A JP2010518431 A JP 2010518431A JP 2010534684 A5 JP2010534684 A5 JP 2010534684A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- composition according
- amino acid
- acid sequence
- cationic peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000003275 alpha amino acid group Chemical group 0.000 claims 6
- 125000002091 cationic group Chemical group 0.000 claims 6
- 108090000765 processed proteins & peptides Proteins 0.000 claims 6
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 2
- 230000000699 topical effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95205907P | 2007-07-26 | 2007-07-26 | |
| US60/952,059 | 2007-07-26 | ||
| PCT/US2008/071350 WO2009015385A1 (en) | 2007-07-26 | 2008-07-28 | Antimicrobial peptide, compositions , and methods of use |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013222846A Division JP5965884B2 (ja) | 2007-07-26 | 2013-10-28 | 抗菌ペプチド、組成物及びその使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010534684A JP2010534684A (ja) | 2010-11-11 |
| JP2010534684A5 true JP2010534684A5 (OSRAM) | 2011-06-02 |
| JP5401457B2 JP5401457B2 (ja) | 2014-01-29 |
Family
ID=40281862
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010518431A Expired - Fee Related JP5401457B2 (ja) | 2007-07-26 | 2008-07-28 | 抗菌ペプチド、組成物及びその使用方法 |
| JP2013222846A Expired - Fee Related JP5965884B2 (ja) | 2007-07-26 | 2013-10-28 | 抗菌ペプチド、組成物及びその使用方法 |
| JP2016132290A Pending JP2017002057A (ja) | 2007-07-26 | 2016-07-04 | 抗菌ペプチド、組成物及びその使用方法 |
| JP2018153719A Active JP6722241B2 (ja) | 2007-07-26 | 2018-08-17 | 抗菌ペプチド、組成物及びその使用方法 |
| JP2020105975A Pending JP2020169190A (ja) | 2007-07-26 | 2020-06-19 | 抗菌ペプチド、組成物及びその使用方法 |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013222846A Expired - Fee Related JP5965884B2 (ja) | 2007-07-26 | 2013-10-28 | 抗菌ペプチド、組成物及びその使用方法 |
| JP2016132290A Pending JP2017002057A (ja) | 2007-07-26 | 2016-07-04 | 抗菌ペプチド、組成物及びその使用方法 |
| JP2018153719A Active JP6722241B2 (ja) | 2007-07-26 | 2018-08-17 | 抗菌ペプチド、組成物及びその使用方法 |
| JP2020105975A Pending JP2020169190A (ja) | 2007-07-26 | 2020-06-19 | 抗菌ペプチド、組成物及びその使用方法 |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US8623811B2 (OSRAM) |
| EP (3) | EP3741380A1 (OSRAM) |
| JP (5) | JP5401457B2 (OSRAM) |
| KR (4) | KR101717275B1 (OSRAM) |
| CN (2) | CN102872447B (OSRAM) |
| AU (1) | AU2008278593B2 (OSRAM) |
| BR (3) | BR122019000258B1 (OSRAM) |
| CA (1) | CA2694046C (OSRAM) |
| CO (1) | CO6260098A2 (OSRAM) |
| CR (1) | CR11239A (OSRAM) |
| CY (2) | CY1118503T1 (OSRAM) |
| DK (2) | DK3120862T3 (OSRAM) |
| ES (2) | ES2805225T3 (OSRAM) |
| HR (1) | HRP20161722T1 (OSRAM) |
| HU (1) | HUE031136T2 (OSRAM) |
| IL (3) | IL203173A (OSRAM) |
| LT (1) | LT2178549T (OSRAM) |
| MX (1) | MX2010000916A (OSRAM) |
| NZ (1) | NZ582459A (OSRAM) |
| PL (1) | PL2178549T3 (OSRAM) |
| PT (2) | PT2178549T (OSRAM) |
| SG (1) | SG188128A1 (OSRAM) |
| SI (1) | SI2178549T1 (OSRAM) |
| WO (1) | WO2009015385A1 (OSRAM) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080226551A1 (en) * | 2006-12-29 | 2008-09-18 | Revance Therapeutics, Inc. | Transport Molecules Using Reverse Sequence HIV-TAT Polypeptides |
| PT2178549T (pt) * | 2007-07-26 | 2016-12-20 | Revance Therapeutics Inc | Péptido antimicrobiano e suas composições |
| US8080518B2 (en) * | 2007-12-05 | 2011-12-20 | Arbor Vita Corporation | Co-administration of an agent linked to an internalization peptide with an anti-inflammatory |
| US8198034B2 (en) | 2008-03-14 | 2012-06-12 | Allergan, Inc. | Immuno-based botulinum toxin serotype A activity assays |
| NO2379104T3 (OSRAM) | 2008-12-31 | 2018-07-28 | ||
| CA2757449A1 (en) * | 2009-04-01 | 2010-10-07 | Revance Therapeutics, Inc. | Methods and compositions for treating skin conditions associated with vascular hyper-reactivity |
| AU2010259986B2 (en) | 2009-06-10 | 2015-04-02 | Nono Inc. | Co-administration of an agent linked to an internalization peptide with an anti-inflammatory |
| KR101975051B1 (ko) | 2009-06-25 | 2019-05-03 | 레반스 테라퓨틱스, 아이엔씨. | 알부민불포함 보툴리눔 독소 제제 |
| US8387798B1 (en) | 2012-04-27 | 2013-03-05 | Abdulmohsen E. A. H. Al-Terki | Mutiple oral and nasal surgical procedures method and kit |
| US10022083B2 (en) | 2011-06-02 | 2018-07-17 | Abdulmohsen E. A. H. Al-Terki | Multiple oral and nasal surgical procedures method and kit |
| FR2997304B1 (fr) | 2012-10-26 | 2017-07-07 | Isp Investments Inc | Utilisation d’un extrait de lin, en tant qu’agent actif activateur de la synthese de peptides antimicrobiens |
| US20140120077A1 (en) | 2012-10-28 | 2014-05-01 | Revance Therapeutics, Inc. | Compositions and Methods for Safe Treatment of Rhinitis |
| US20140242110A1 (en) * | 2013-02-28 | 2014-08-28 | Dt Scimed, Llc | Dose, localization, and formulation of botulinum toxins in skin and muscle |
| US11484580B2 (en) | 2014-07-18 | 2022-11-01 | Revance Therapeutics, Inc. | Topical ocular preparation of botulinum toxin for use in ocular surface disease |
| US11446236B2 (en) | 2015-08-05 | 2022-09-20 | Cmpd Licensing, Llc | Topical antimicrobial compositions and methods of formulating the same |
| US11684567B2 (en) | 2015-08-05 | 2023-06-27 | Cmpd Licensing, Llc | Compositions and methods for treating an infection |
| US11793783B2 (en) | 2015-08-05 | 2023-10-24 | Cmpd Licensing, Llc | Compositions and methods for treating an infection |
| BR112018005316A2 (pt) | 2015-09-17 | 2018-12-11 | Contrafect Corporation | ?uso de lisina para restabelecer/aumentar a atividade antibacteriana na presença de surfactante pulmonar de antibióticos inibidos desse modo? |
| US10105381B2 (en) * | 2016-05-23 | 2018-10-23 | Cmpd Licensing, Llc | Compositions and methods for treating an infection |
| US10144767B2 (en) * | 2016-08-18 | 2018-12-04 | Board Of Regents Of The University Of Nebraska | Anti-microbial peptides and coatings |
| MX2019005833A (es) * | 2016-11-21 | 2019-10-30 | Eirion Therapeutics Inc | Administracion transdermica de agentes grandes. |
| EP3675900A4 (en) | 2017-08-28 | 2021-05-05 | Revance Therapeutics, Inc. | Transmucosal botulinum toxin compositions, kits, and methods for treating bladder disorders |
| CN107556374B (zh) * | 2017-08-30 | 2020-02-07 | 四川大学 | 唾液富脯蛋白仿生防龋功能多肽、其衍生物和盐及其应用 |
| CN107353334B (zh) * | 2017-08-30 | 2020-02-07 | 四川大学 | 基于唾液富酪蛋白的仿生防龋多肽、其衍生物和盐及应用 |
| JP7266202B2 (ja) * | 2018-02-19 | 2023-04-28 | 株式会社ファンケル | 化粧料及び抗炎症剤 |
| CA3179706A1 (en) * | 2020-04-08 | 2021-10-14 | Amicrobe, Inc. | Compositions and uses of locally applied synthetic amino acid polymers for prevention and treatment of viral infections |
| WO2025059665A1 (en) | 2023-09-15 | 2025-03-20 | Revance Therapeutics, Inc. | Serial treatment with botulinum toxin for cervical dystonia |
| WO2025064729A1 (en) | 2023-09-19 | 2025-03-27 | Revance Therapeutics, Inc. | Treatment with botulinum toxin in patients in need of a rapid onset cosmetic effect and smoother skin appearance |
| WO2025072381A1 (en) | 2023-09-25 | 2025-04-03 | Revance Therapeutics, Inc. | Methods for determining influence of carrier peptide on the binding of a therapeutic protein to a cell membrane |
Family Cites Families (61)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5744166A (en) | 1989-02-25 | 1998-04-28 | Danbiosyst Uk Limited | Drug delivery compositions |
| US5804604A (en) | 1989-12-21 | 1998-09-08 | Biogen, Inc. | Tat-derived transport polypeptides and fusion proteins |
| US5674980A (en) | 1989-12-21 | 1997-10-07 | Biogen Inc | Fusion protein comprising tat-derived transport moiety |
| AU4037793A (en) | 1992-04-23 | 1993-11-29 | Allelix Biopharmaceuticals Inc. | Treatment of herpesvirus infection |
| DE656950T1 (de) | 1992-08-21 | 1996-03-14 | Biogen Inc | Tat-derivate transport polypeptide. |
| WO1995011038A1 (en) * | 1993-10-22 | 1995-04-27 | Allelix Biopharmaceuticals Inc. | Treatment of cytomegalovirus infection |
| EP1790352B1 (en) | 1993-12-28 | 2008-07-09 | Allergan, Inc. | Use of botulinum toxin for the manufacture of a medicament for reducing low back pain |
| US6232295B1 (en) | 1994-10-12 | 2001-05-15 | Jon Faiz Kayyem | Cell-specific contrast agent and gene delivery vehicles |
| GB9508204D0 (en) | 1995-04-21 | 1995-06-07 | Speywood Lab Ltd | A novel agent able to modify peripheral afferent function |
| JP3860838B2 (ja) | 1995-08-23 | 2006-12-20 | ユニバーシティー オブ ブリティッシュ コロンビア | 抗微生物性陽イオン性ペプチドおよびそのスクリーニング方法 |
| US6043218A (en) * | 1996-10-22 | 2000-03-28 | Medical University Of South Carolina | Positively charged non-natural amino acids, methods of making thereof, and use thereof in peptides |
| GB9623051D0 (en) | 1996-11-06 | 1997-01-08 | Schacht Etienne H | Delivery of DNA to target cells in biological systems |
| US6221355B1 (en) | 1997-12-10 | 2001-04-24 | Washington University | Anti-pathogen system and methods of use thereof |
| JP2002508187A (ja) | 1997-12-12 | 2002-03-19 | オニックス ファーマシューティカルズ，インコーポレイティド | Ｐ５３＋新生細胞の選択的殺死及び診断 |
| ATE314859T1 (de) | 1998-10-27 | 2006-02-15 | Mayo Foundation | Botulinumtoxine zur verstärkung der wundheilung |
| JP2002531113A (ja) | 1998-12-10 | 2002-09-24 | ワシントン大学 | 蛋白質の形質導入システムおよびその使用法 |
| EP1140021B1 (en) | 1998-12-23 | 2004-08-04 | Idea Ag | Improved formulation for topical non-invasive application in vivo |
| US7056656B1 (en) | 1999-01-25 | 2006-06-06 | University Of Medicine And Dentistry Of New Jersey | Tat-derived oligourea and its method of production and use in high affinity and specific binding HIV-1 TAR RNA |
| US20030236214A1 (en) | 1999-06-09 | 2003-12-25 | Wolff Jon A. | Charge reversal of polyion complexes and treatment of peripheral occlusive disease |
| US7008924B1 (en) | 1999-07-21 | 2006-03-07 | Amgen, Inc. | VGF fusion polypeptides |
| US6669951B2 (en) | 1999-08-24 | 2003-12-30 | Cellgate, Inc. | Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| US6544548B1 (en) | 1999-09-13 | 2003-04-08 | Keraplast Technologies, Ltd. | Keratin-based powders and hydrogel for pharmaceutical applications |
| US6844324B1 (en) | 1999-11-12 | 2005-01-18 | Massachusetts Institute Of Technology | Modular peptide mediated intracellular delivery system and uses therefore |
| US20030118598A1 (en) | 2000-02-08 | 2003-06-26 | Allergan, Inc. | Clostridial toxin pharmaceutical compositions |
| US6670322B2 (en) | 2000-06-01 | 2003-12-30 | Wisconsin Alumni Research Foundation | Method of targeting pharmaceuticals to motor neurons |
| US20040220100A1 (en) | 2000-07-21 | 2004-11-04 | Essentia Biosystems, Inc. | Multi-component biological transport systems |
| US20030215412A1 (en) | 2000-07-21 | 2003-11-20 | Essentia Biosystems, Inc. | Induction of hair growth with vascular endothelial growth factor |
| ES2617692T3 (es) | 2000-07-21 | 2017-06-19 | Revance Therapeutics, Inc. | Sistemas de transporte de agentes biológicos de múltiples componentes |
| US6696038B1 (en) | 2000-09-14 | 2004-02-24 | Expression Genetics, Inc. | Cationic lipopolymer as biocompatible gene delivery agent |
| US20020127247A1 (en) | 2000-11-17 | 2002-09-12 | Allergen Sales, Inc. | Modified clostridial neurotoxins with altered biological persistence |
| WO2002065986A2 (en) | 2001-02-16 | 2002-08-29 | Cellgate, Inc. | Transporters comprising spaced arginine moieties |
| AU2002305539A1 (en) * | 2001-05-09 | 2002-11-18 | Yale University | Toll/interleukin-1 receptor adaptor protein (tirap) |
| US7060498B1 (en) | 2001-11-28 | 2006-06-13 | Genta Salus Llc | Polycationic water soluble copolymer and method for transferring polyanionic macromolecules across biological barriers |
| US7169814B2 (en) | 2001-12-11 | 2007-01-30 | The Board Of Trustees Of The Leland Stanford Junior University | Guanidinium transport reagents and conjugates |
| AU2003216389A1 (en) | 2002-02-21 | 2003-09-09 | Essentia Biosystems, Inc. | Induction of hair growth with vascular endothelial growth factor |
| US20030215395A1 (en) | 2002-05-14 | 2003-11-20 | Lei Yu | Controllably degradable polymeric biomolecule or drug carrier and method of synthesizing said carrier |
| US20040009180A1 (en) | 2002-07-11 | 2004-01-15 | Allergan, Inc. | Transdermal botulinum toxin compositions |
| JP4154218B2 (ja) * | 2002-11-27 | 2008-09-24 | 寛紀 高麗 | 新規抗菌性ポリペプチドとその利用 |
| IL153557A0 (en) * | 2002-12-19 | 2003-07-06 | Yitzchak Hillman | Antibodies and antagonists to antimicrobial peptides for the purpose of treating, inhibiting and preventing auto immune diseases |
| US20060115480A1 (en) * | 2002-12-19 | 2006-06-01 | Yitzchak Hillman | Disease treatment via antimicrobial peptide inhibitors |
| WO2004069182A2 (en) * | 2003-02-01 | 2004-08-19 | Neuralab Limited | Active immunization to generate antibodies to soluble a-beta |
| WO2004084805A2 (en) | 2003-03-19 | 2004-10-07 | The J. David Gladstone Institutes | Acetylated tat polypeptides and methods of use thereof |
| US7125842B2 (en) * | 2003-04-07 | 2006-10-24 | Canbas Co. Ltd. | Anti-fungal compounds and methods of use |
| ZA200602754B (en) * | 2003-09-12 | 2007-06-27 | Univ British Columbia | Effectors of innate immunity determination |
| JP2005120050A (ja) * | 2003-10-20 | 2005-05-12 | Toagosei Co Ltd | 新規抗菌性ペプチドとその利用 |
| EP2656859B1 (en) | 2004-03-03 | 2015-10-21 | ReVance Therapeutics, Inc. | Topical application and transdermal delivery of botulinum toxins |
| MXPA06009897A (es) | 2004-03-03 | 2008-02-07 | Revance Therapeutics Inc | Composiciones y metodos para el diagnostico topico y el transporte terapeutico. |
| BRPI0514420B1 (pt) * | 2004-08-18 | 2022-05-17 | Novabiotics Limited | Peptídeo, ou um sal farmaceuticamente aceitável do mesmo, e, uso de um peptídeo |
| EP1824976A4 (en) | 2004-11-12 | 2008-07-09 | Univ British Columbia | ANTIMICROBIAL PEPTIDES |
| EP1656951A1 (en) * | 2004-11-12 | 2006-05-17 | Xigen S.A. | Conjugates with enhanced cell uptake activity |
| EP1661912A1 (en) | 2004-11-29 | 2006-05-31 | Xigen S.A. | Fusion protein comprising a BH3-domain of a BH3-only protein |
| JP4730584B2 (ja) * | 2004-12-06 | 2011-07-20 | 東亞合成株式会社 | 抗菌ペプチド及びその利用 |
| JP2006238751A (ja) * | 2005-03-02 | 2006-09-14 | Toagosei Co Ltd | ベロ毒素結合性を有する抗菌ペプチド及びその利用 |
| EP1856139B1 (en) | 2005-03-03 | 2011-04-27 | Revance Therapeutics, Inc. | Compositions and methods for topical application and transdermal delivery of an oligopeptide |
| MX2007010673A (es) | 2005-03-03 | 2008-04-07 | Revance Therapeutics Inc | Composiciones y metodos para la aplicacion topica y el suministro transdermico de toxinas botulinicas. |
| JP5388568B2 (ja) | 2005-03-30 | 2014-01-15 | ルバンス セラピュティックス インク． | ざ瘡を治療するための組成物及び方法 |
| BRPI0618753A2 (pt) | 2005-11-17 | 2011-09-13 | Revance Therapeutics Inc | composição para liberação transdérmica de toxina botulìnica e método de administração |
| WO2008082889A2 (en) | 2006-12-29 | 2008-07-10 | Revance Therapeutics, Inc. | Compositions and methods of topical application and transdermal delivery of botulinum toxins stabilized with polypeptide fragments derived from hiv-tat |
| US20080226551A1 (en) | 2006-12-29 | 2008-09-18 | Revance Therapeutics, Inc. | Transport Molecules Using Reverse Sequence HIV-TAT Polypeptides |
| PT2178549T (pt) * | 2007-07-26 | 2016-12-20 | Revance Therapeutics Inc | Péptido antimicrobiano e suas composições |
| NO2379104T3 (OSRAM) | 2008-12-31 | 2018-07-28 |
-
2008
- 2008-07-28 PT PT88266085T patent/PT2178549T/pt unknown
- 2008-07-28 BR BR122019000258-4A patent/BR122019000258B1/pt active IP Right Grant
- 2008-07-28 KR KR1020157019647A patent/KR101717275B1/ko active Active
- 2008-07-28 EP EP20166266.5A patent/EP3741380A1/en active Pending
- 2008-07-28 NZ NZ582459A patent/NZ582459A/en unknown
- 2008-07-28 EP EP16184094.7A patent/EP3120862B1/en active Active
- 2008-07-28 US US12/669,705 patent/US8623811B2/en active Active
- 2008-07-28 SG SG2013009832A patent/SG188128A1/en unknown
- 2008-07-28 CN CN201210375756.5A patent/CN102872447B/zh active Active
- 2008-07-28 DK DK16184094.7T patent/DK3120862T3/da active
- 2008-07-28 PL PL08826608T patent/PL2178549T3/pl unknown
- 2008-07-28 BR BR122019000266-5A patent/BR122019000266B1/pt active IP Right Grant
- 2008-07-28 CA CA2694046A patent/CA2694046C/en active Active
- 2008-07-28 MX MX2010000916A patent/MX2010000916A/es active IP Right Grant
- 2008-07-28 KR KR1020107003133A patent/KR101722038B1/ko active Active
- 2008-07-28 CN CN200880100641.7A patent/CN101842107B/zh active Active
- 2008-07-28 KR KR1020177002763A patent/KR20170016031A/ko not_active Ceased
- 2008-07-28 ES ES16184094T patent/ES2805225T3/es active Active
- 2008-07-28 WO PCT/US2008/071350 patent/WO2009015385A1/en not_active Ceased
- 2008-07-28 JP JP2010518431A patent/JP5401457B2/ja not_active Expired - Fee Related
- 2008-07-28 HU HUE08826608A patent/HUE031136T2/en unknown
- 2008-07-28 HR HRP20161722TT patent/HRP20161722T1/hr unknown
- 2008-07-28 PT PT161840947T patent/PT3120862T/pt unknown
- 2008-07-28 ES ES08826608.5T patent/ES2609914T3/es active Active
- 2008-07-28 LT LTEP08826608.5T patent/LT2178549T/lt unknown
- 2008-07-28 SI SI200831732T patent/SI2178549T1/sl unknown
- 2008-07-28 KR KR1020187007958A patent/KR102088949B1/ko active Active
- 2008-07-28 EP EP08826608.5A patent/EP2178549B1/en active Active
- 2008-07-28 DK DK08826608.5T patent/DK2178549T3/en active
- 2008-07-28 BR BRPI0813627-0A patent/BRPI0813627B1/pt active IP Right Grant
- 2008-07-28 AU AU2008278593A patent/AU2008278593B2/en active Active
-
2010
- 2010-01-06 IL IL203173A patent/IL203173A/en active IP Right Grant
- 2010-01-27 CR CR11239A patent/CR11239A/es not_active Application Discontinuation
- 2010-02-26 CO CO10023449A patent/CO6260098A2/es not_active Application Discontinuation
-
2012
- 2012-12-20 IL IL223785A patent/IL223785A/en active IP Right Grant
- 2012-12-20 IL IL223784A patent/IL223784A/en active IP Right Grant
-
2013
- 2013-10-28 JP JP2013222846A patent/JP5965884B2/ja not_active Expired - Fee Related
-
2016
- 2016-07-04 JP JP2016132290A patent/JP2017002057A/ja active Pending
- 2016-12-14 CY CY20161101296T patent/CY1118503T1/el unknown
-
2018
- 2018-08-17 JP JP2018153719A patent/JP6722241B2/ja active Active
-
2020
- 2020-06-19 JP JP2020105975A patent/JP2020169190A/ja active Pending
- 2020-07-27 CY CY20201100692T patent/CY1123176T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010534684A5 (OSRAM) | ||
| RU2016146198A (ru) | Терапевтические dll4-связывающие белки | |
| JP2011136981A5 (OSRAM) | ||
| JP2013507132A5 (OSRAM) | ||
| JP2010088434A5 (OSRAM) | ||
| JP2012034696A5 (OSRAM) | ||
| JP2010265269A5 (OSRAM) | ||
| JP2007045829A5 (OSRAM) | ||
| WO2008093060A3 (en) | Peptides and their use | |
| JP2012126742A5 (OSRAM) | ||
| JP2017048194A5 (OSRAM) | ||
| JP2015513533A5 (OSRAM) | ||
| JP2013510581A5 (OSRAM) | ||
| JP2011155981A5 (OSRAM) | ||
| WO2007149542A3 (en) | Antimicrobial kinocidin compositions and methods of use | |
| WO2007122581A3 (en) | Compositions and kits of phenylephrine | |
| JP2009225798A5 (OSRAM) | ||
| JP2010065037A5 (OSRAM) | ||
| WO2008011335A3 (en) | Metal binding compounds, metal binding compositions, and their uses | |
| JP2009504138A5 (OSRAM) | ||
| EA201001014A1 (ru) | Фармацевтически приемлемые соли метил (3-{[[3-(6-амино-2-бутокси-8-оксо-7,8-дигидро-9h-пурин-9-ил)пропил](3-морфолин-4-илпропил)амино]метил}фенил)ацетата и их применение в терапии | |
| WO2013000922A9 (en) | Ccr2 antagonist peptides | |
| DE602005008996D1 (de) | Radiofluorierte peptide | |
| TW200942524A (en) | Novel aminomethyl benzene derivatives | |
| JP2015533791A5 (OSRAM) |